From 2013 to 2016, antidepressant medicine sales in Italy experienced a consistent decline, with the most significant drop occurring between 2014 and 2015 (-21.74%). However, from 2017 onwards, sales stabilized around 1.7 units through 2023, showing no year-on-year variation. For the current year (2023), the value stands at 1.7 units.
Looking ahead, the forecast indicates a slight decrease starting in 2024, reaching 1.5 units by 2028. The forecasted Compound Annual Growth Rate (CAGR) for the next five years is -1.28%, indicating a minor annual decline.
Future trends to watch for include potential impacts of new treatment options, changes in healthcare policies, and increased awareness of mental health, which could influence antidepressant sales dynamics.
